# EDGEWELL PERSONAL CARE Co: Form 10-Q for the period ended Mar 31, 2020

- Company: [EDGEWELL PERSONAL CARE Co](/companies/epc.md) (CIK 1096752)
- Form: 10-Q
- Filed: 2020-05-07
- Accepted by EDGAR: May 7, 2020, 16:57 ET
- Period: 2020-03-31
- Accession: 0001096752-20-000024
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1096752/000109675220000024/epc-20200331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1096752/000109675220000024/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-01-01 to 2020-03-31 | $523.0m | us-gaap:Revenues |
| Revenue | 6 months, 2019-10-01 to 2020-03-31 | $977.0m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2020-01-01 to 2020-03-31 | $280.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2019-10-01 to 2020-03-31 | $540.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-01-01 to 2020-03-31 | $243.0m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2019-10-01 to 2020-03-31 | $436.1m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-01-01 to 2020-03-31 | $13.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2019-10-01 to 2020-03-31 | $27.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-01-01 to 2020-03-31 | $121.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2019-10-01 to 2020-03-31 | $216.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2020-01-01 to 2020-03-31 | $13.9m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2019-10-01 to 2020-03-31 | $28.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-01-01 to 2020-03-31 | $8.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2019-10-01 to 2020-03-31 | $15.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | $19.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2019-10-01 to 2020-03-31 | $41.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-01-01 to 2020-03-31 | $0.36 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2019-10-01 to 2020-03-31 | $0.77 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-01-01 to 2020-03-31 | $0.36 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2019-10-01 to 2020-03-31 | $0.77 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-01-01 to 2020-03-31 | 54,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2019-10-01 to 2020-03-31 | 54,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2019-10-01 to 2020-03-31 | $17.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2019-10-01 to 2020-03-31 | $16.8m | us-gaap:PaymentsToAcquireProductiveAssets |
| Current assets | at 2020-03-31 | $989.2m | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $3.31bn | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $486.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-03-31 | $1.96bn | us-gaap:Liabilities |
| Long-term debt | at 2020-03-31 | $1.10bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-03-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2020-03-31 | $1.35bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 51,533 characters.

(in millions, except per share data, unaudited)

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and the accompanying notes included in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K filed with the SEC on November 26, 2019 (the “2019 Annual Report”). The following discussion may contain forward-looking statements that reflect our plans, estimates, and beliefs and involve risks, uncertainties, and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed within “Forward-Looking Statements” below and in Item 1A. Risk Factors and “Forward-Looking Statements” included within our 2019 Annual Report.

#### Forward-Looking Statements

This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Edgewell Personal Care Company (“Edgewell”, “we” or “our Company”) or any of our businesses. Forward-looking statements generally can be identified by the use of words or phrases such as “believe,” “expect,” “expectation,” “anticipate,” “may,” “could,” “intend,” “belief,” “estimate,” “plan,” “target,” “predict,” “likely,” “will,” “should,” “forecast,” “outlook,” or other similar words or phrases. These statements are not based on historical facts, but instead reflect our expectations, estimates, or projections concerning future results or events, including, without limitation, the future earnings and performance of our Company or any of our businesses. Many factors outside our control (including the ongoing COVID-19 outbreak), could affect the realization of these estimates. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this report are only made as of the date of this report, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.

In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly affect the forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Risks and uncertainties include those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of our 2019 Annual Report on Form 10-K and Item 1A Risk Factors of Part II of this Quarterly Report on Form 10-Q.

#### Non-GAAP Financial Measures

While we report financial results in accordance with GAAP, this discussion also includes non-GAAP measures. These Non-GAAP measures are referred to as “adjusted” or “organic” and exclude items such as restructuring charges, acquisition and integration planning costs, the disposition of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, legal settlement expenses, and the amortization of intangibles. Reconciliations of non-GAAP measures are included within this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. Given the various significant events, including the Project Fuel restructuring, the efforts to acquire Harry’s, Inc. and the subsequent termination of the merger agreement with Harry's, we view the use of non-GAAP measures that take into account the impact of these unique events as particularly valuable in understanding our underlying operational results and providing insights into future performance. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is also a component in determining management’s incentive compensation. Finally, we believe this information provides more transparency. The following provides additional detail on our non-GAAP measures:

- We analyze our net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency, acquisitions, and divestitures (including the disposition of the Infant and Pet Care business). This information is provided because these types of fluctuations can distort the underlying change in net sales and segment profit either positively or negatively.
- Adjusted net earnings and adjusted earnings per share are defined as net earnings and diluted earnings per share excluding items such as restructuring charges, acquisition and integration planning costs, the gain or loss on the disposal of a business, business development evaluation costs, legal settlement expenses, and the related tax effects of these items.
- Adjusted effective tax rate is defined as the effective tax rate excluding items such as restructuring charges, acquisition and integration planning costs, the gain or loss on the disposal of a business, business development evaluation costs, legal settlement expenses, and the related tax effects of these items from the income tax provision and earnings before income taxes.
- Free cash flow is defined as net cash from operating activities less net capital expenditures. Free cash flow conversion is defined as free cash flow as a percentage of net earnings adjusted for the net impact of non-cash impairments.

All comparisons are with the same period in the prior year, unless otherwise noted.

#### Industry and Market Data

Unless we indicate otherwise, we base the information concerning our industry contained or incorporated by reference herein on our general knowledge of and expectations concerning the industry. Our market position, market share, and industry market size are based on our estimates using internal data and external data from various industry analyses, our internal research and adjustments, and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses and cannot guarantee its accuracy or completeness. In addition, we believe that data regarding the industry, market size and our market position and market share within such industry provide general guidance but are inherently imprecise and have not been verified by any independent source. Further, our estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those discussed in “Item 1A. Risk Factors” in Part II of this Quarterly Report on Form 10-Q and in Item 1A. Risk Factors in Part I of our Annual Report on Form 10-K. These, and other factors, could cause results to differ materially from those expressed in the estimates and assumptions. You are cautioned not to place undue reliance on this data.

Retail sales for purposes of market size, market position and market share information are based on retail sales in U.S. dollars.

#### Trademarks and Trade Names

We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which appear throughout this Quarterly Report on Form 10-Q. We also may refer to brand names, trademarks, service marks and trade names of other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their respective owners.

#### Impact of COVID-19

On March 11, 2020, the World Health Organization declared COVID-19 a worldwide pandemic, which has impacted individuals, families, companies and economies around the world. Due to the uncertainty surrounding COVID-19 and its fast spreading nature, global leaders have taken significant measures to keep their people safe, including asking people to stay home unless they are considered essential employees, closing offices and storefront locations, and cancelling all non-essential travel, for an indefinite period of time. As governmental policies continue to evolve, they will continue to shape the Company’s response to COVID-19. While the full impact of COVID-19 is not certain at this time and although we cannot estimate with reasonable certainty the impact this will have on the global and local economies or our business, the Company has taken significant measures to protect its employees and business.

The Company’s top priority during this time has been the health and welfare of our employees and customers. Additional measures have been put in place at all of our manufacturing locations to ensure the safety of our employees, including thermal scanning, using proper protective gear, making hand sanitizer widely available throughout the facilities and following social distancing guidelines. Additionally, we have implemented work-from-home policies for our employees that can work from home and have cancelled all non-essential travel. We have not had any operational disruption across our manufacturing and distribution facilities as the majority of our facilities have not been impacted by governmental closure orders and have been able to operate without disruption. There has been a slight increase in the level of absenteeism as our employees are taking intermittent leave in order to care for family members, however, this has not caused a significant disruption in our production.

As noted below in the discussion of our consolidated results, we have had strong results for the three months ended March 31, 2020, which has been driven by an increase in demand for our Skin Care, primarily Wet Ones, and our Feminine Care products, partially due to a change in consumer habits and increased pantry loading as a result of COVID-19. We expect to see continued strong demand for Wet Ones going forward. Due to the seasonality of our Sun Care products and the impact that stay at home measures may have on future travel and outdoor activities, we expect that there may be a decline in the demand for these products in the near term. The impact that COVID-19 may have on our customers, their cash flows and ability to operate is not fully known at this time. However, in some cases we have seen changes in payment patterns, requests for extended payment terms or reduction in customer operations, resulting in an increase in our bad debt expense for the three months ending March 31, 2020. As the duration and severity of the COVID-19 pandemic could continue to impact economic conditions which could impact consumer spending and demand, we will continue to closely monitor the impact that this has on our business and customers.

We continue to closely monitor our supply chain and to date have not experienced any issues securing key ingredients for our products. The duration and severity of COVID-19 could result in disruptions related to our key suppliers, however, the impact, timing and severity of potential disruptions cannot be reasonably estimated at this time.

We experienced increased volatility in foreign currency exchange rates and commodity prices in the three months ended March 31, 2020, which is largely due to the economic uncertainty from COVID-19 and the depreciation of certain foreign currencies against the U.S. dollar. We expect to see continued volatility in the foreign currency exchange rates; however, we cannot estimate the impact that this will have at this time.

We expect to maintain adequate liquidity during these uncertain times. As noted in “Liquidity and Capital Resources” below, COVID-19 has not had a significant impact on our liquidity, cash flows or capital resources, including our ability to enter into the Credit Agreement. We will continue to monitor the impact that COVID-19 has on our liquidity needs and the current economic market.

### Significant Events

### Divestiture

On December 17, 2019, we completed the sale of our Infant and Pet Care business included in the All Other segment for $122.5 which included consideration for providing services for up to one year under a transition services agreement. For further information on the divestiture of the Infant and Pet Care business, refer to Note 2 of Notes to Condensed Consolidated Financial Statements.

### Project Fuel

As previously outlined, Project Fuel is an enterprise-wide transformational initiative that was launched in the second fiscal quarter of 2018 to address all aspects of our business and cost structure, simplifying and transforming our organization, structure and key processes. Project Fuel is facilitating further re-investment in our growth strategy while enabling us to achieve our desired future state operations.

We expect Project Fuel will generate $225 to $240 in total annual gross savings by the end of the 2021 fiscal year. It is expected that the savings generated will be used to fuel investments and brand building in strategic growth initiatives, offset anticipated operational cost headwinds from inflation and other rising input costs and improve our overall profitability and cash flows. Project Fuel related savings were approximately $18 and $33 for the three and six months ended March 31, 2020, respectively, bringing cumulative savings to $170 for Project Fuel to date.

To implement the restructuring element of Project Fuel, we expect to incur one-time pre-tax charges of approximately $130 to $140 through the end of the 2021 fiscal year. Restructuring and related charges were $12.4 and $20.4 for the three and six months ended March 31, 2020, respectively, bringing cumulative charges to $115 for the project to date.

Capital expenditures for Project Fuel were $4.5 and $9.3 for the three and six months ended March 31, 2020, respectively.

For further information on our restructuring projects, refer to Note 3 of Notes to Condensed Consolidated Financial Statements.

### Executive Summary

The following is a summary of key results for the second quarter and first six months of fiscal 2020 compared to the second quarter and first six months of fiscal 2019. Net earnings and earnings per share (“EPS”) for the periods presented were impacted by restructuring charges, acquisition and integration planning costs, the gain on the disposition of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, legal settlement expenses, and the impact of the Tax Act, as described in the table below. The impact of these items on reported net earnings and EPS are provided as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, both of which are non-GAAP measures.

### Second Quarter of Fiscal 2020

- Net sales in the second quarter of fiscal 2020 were $523.0, down 4.3% compared to the prior year quarter, inclusive of a 5.8% decline from the sale of the Infant and Pet Care business and a 0.9% decline due to currency movements. Excluding the divestiture of the Infant and Pet Care business and currency movements, organic net sales increased 2.4% compared to the prior year quarter, due to growth in Sun and Skin Care and Feminine Care from increased volumes due to COVID-19, which was partially offset by declines in Wet Shave.
- Net earnings in the second quarter of fiscal 2020 were $19.5 compared to $48.2 in the prior year quarter. On an adjusted basis, as illustrated in the following table, net earnings for the second quarter of fiscal 2020 decreased 18.0% to $50.4. The decline was partially driven by the sale of the Infant and Pet Care business. Additionally, the decline was impacted by lower gross margins from lower sales in Wet Shave and unfavorable foreign currency fluctuations increasing other expense.
- Net earnings per diluted share during the second quarter of fiscal 2020 were $0.36 compared to $0.89 in the prior year quarter. On an adjusted basis, as illustrated in the following table, net earnings per diluted share during the second quarter of fiscal 2020 was $0.92 compared to $1.13 in the prior year quarter.

|  | Quarter Ended March 31, Net Earnings 2020 | 2019 | Diluted EPS 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| **Net Earnings and Diluted EPS — GAAP** | $19.5 | $48.2 | $0.36 | $0.89 |
| Restructuring and related costs, net | 12.4 | 15.4 | 0.23 | 0.28 |
| Acquisition and integration planning costs | 25.5 | 0.5 | 0.47 | 0.01 |
| Gain on sale of Infant and Pet Care business | 1.1 | — | 0.02 | — |
| Feminine and Infant Care evaluation costs | — | 1.0 | — | 0.02 |
| Sun Care reformulation costs | — | 0.4 | — | 0.01 |
| Income taxes (1) | (8.1) | (4.0) | (0.16) | (0.08) |
| **Adjusted Net Earnings and Adjusted Diluted EPS — Non-GAAP** | $50.4 | $61.5 | $0.92 | $1.13 |
| Weighted-average shares outstanding — Diluted |  |  | 54.5 | 54.3 |

(1) Includes Income tax expense for adjustments to Net Earnings and Diluted EPS — GAAP for fiscal 2020 and 2019.

### First Six Months of Fiscal 2020

- Net sales for the first six months of fiscal 2020 decreased 2.7% to $977.0, inclusive of a 3.3% decline from the sale of the Infant and Pet Care business and a 0.7% decline due to currency movements. Excluding the divestiture of the Infant and Pet Care business and currency movements, organic net sales increased 1.3% compared to the prior year period, due to growth in Sun and Skin Care and Feminine Care from increased volumes, which was partially offset by declines in Wet Shave.
- Net earnings for the first six months of fiscal 2020 were $41.9 compared to $47.8 in the prior year. On an adjusted basis, as illustrated in the following table, net earnings for the first six months of fiscal 2020 decreased 1.7% to $80.3. The decline was partially driven by the sale of the Infant and Pet Care business. The decline was also impacted by lower net sales and gross margin and unfavorable currency, partially offset by lower advertising and promotion expense (“A&P”) and lower interest expense.
- Net earnings per diluted share during the first six months of fiscal 2020 were $0.77 compared to $0.88 in the prior year period. On an adjusted basis, as illustrated in the following table, net earnings per diluted share during the first six months of fiscal 2020 were $1.47 compared to $1.50 in the prior year quarter.

|  | Six Months Ended March 31, Net Earnings 2020 | 2019 | Diluted EPS 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| **Net Earnings and Diluted EPS — GAAP** | $41.9 | $47.8 | $0.77 | $0.88 |
| Restructuring and related costs, net | 20.4 | 33.9 | 0.37 | 0.62 |
| Acquisition and integration planning costs | 31.7 | 1.0 | 0.58 | 0.02 |
| Gain on sale of Infant and Pet Care business | (4.1) | — | (0.08) | — |
| Feminine and Infant Care evaluation costs | 0.3 | 1.0 | 0.01 | 0.02 |
| Legal settlement expenses | — | 0.9 | — | 0.02 |
| Sun Care reformulation costs | — | 0.5 | — | 0.01 |
| Income taxes (1) | (9.9) | (3.4) | (0.18) | (0.07) |
| **Adjusted Net Earnings and Adjusted Diluted EPS — Non-GAAP** | $80.3 | $81.7 | $1.47 | $1.50 |
| Weighted-average shares outstanding — Diluted |  |  | 54.5 | 54.3 |

(1) Includes Income tax expense for adjustments to Net Earnings and Diluted EPS — GAAP for fiscal 2020 and 2019. Additionally, the six months ended March 31, 2019 was impacted $4.7 as a result of the transition tax from the Tax Act.

### Operating Results

The following table presents changes in net sales for the second quarter and first six months of fiscal 2020, as compared to the corresponding period in fiscal 2019, and provides a reconciliation of organic net sales to reported amounts.

### Net Sales

| Net Sales - Total Company Period Ended March 31, 2020 | Q2 | % Chg | Six Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Net sales - prior year | $546.7 |  | $1,003.8 |  |
| Organic | 13.0 | 2.4% | 13.0 | 1.3% |
| Impact of Infant and Pet Care divestiture | (31.7) | (5.8)% | (32.7) | (3.3)% |
| Impact of currency | (5.0) | (0.9)% | (7.1) | (0.7)% |
| Net sales - current year | $523.0 | (4.3)% | $977.0 | (2.7)% |

For the second quarter of fiscal 2020, net sales were $523.0, a 4.3% decrease when compared with the prior year period. Excluding the impact of the Infant and Pet Care business divestiture and currency movements, organic net sales increased 2.4% versus the prior year period. Organic net sales growth in the quarter was largely driven by increases in sales of Feminine Care and Wet Ones products, partly attributable to COVID-19. Excluding the COVID-19 related increases, organic net sales growth was flat with the prior year period and consistent with recent trends.

For the first six months of fiscal 2020, net sales decreased 2.7%. Excluding the impact of the Infant and Pet Care business divestiture and currency movements, organic net sales increased 1.3% versus the prior year period. From a geographic perspective, organic net sales in North America grew 3.1% while International decreased 1.4%. Growth in North America was driven by Skin Care and Feminine Care while the declines in International markets were driven by lower Wet Shave volumes.

For further discussion regarding net sales, including a summary of reported versus organic changes, see “Segment Results.”

### Gross Profit

Gross profit was $243.0 during the second quarter of fiscal 2020, as compared to $250.9 in the prior year period. Gross margin as a percent of net sales for the second quarter of fiscal 2020 was 46.5%, representing a 60-basis point increase over the prior year gross margin percentage of 45.9%. Excluding the impact of the Infant and Pet Care business divestiture, currency and supply chain costs associated with COVID-19, gross margin percentage increased 50 basis points compared to the prior year period. The increase was a result of favorable Sun Care pricing and lower cost of goods sold, partly offset by unfavorable volume mix.

Gross profit was $436.1 during the first six months of fiscal 2020, as compared to $444.4 in the prior year period. Gross margin as a percent of net sales for the first six months of fiscal 2019 was 44.6%, up 30 basis points as compared to the prior year period. The improvement compared to the prior year period was primarily related to favorable cost mix in Wet Shave and Feminine Care. Lower volumes in Wet Shave negatively impacted gross margin. Additionally, the gross margin percentage was favorably impacted by the divestiture of the Infant and Pet Care business, which had lower margins.

### Selling, General and Administrative Expense

SG&A was $121.5 in the second quarter of fiscal 2020, or 23.2% of net sales, as compared to $98.1 in the prior year period, or 17.9% of net sales. Excluding SG&A associated with acquisitions and integration planning, Project Fuel, and the divestiture of the Infant and Pet Care business, SG&A as a percent of net sales decreased by 10 basis points to 16.9% of net sales. The decrease in SG&A as a percent of sales was driven by the cycling of higher temporary personnel costs in the prior year period, lower compensation expense this period and Project Fuel savings, mostly offset by an increase in the bad debt reserve.

SG&A was $216.5 in the first six months of fiscal 2020, or 22.2% of net sales, as compared to $185.4 in the prior year period, or 18.5% of net sales. Excluding SG&A costs associated with acquisition and integration planning, Project Fuel, the divestiture of the Infant and Pet Care business, and the impact of foreign currency, SG&A as a percent of net sales was flat compared to the six months ended March 31, 2019, respectively, as lower compensation costs were offset by an increase in the bad debt reserve.

### Advertising and Sales Promotion Expense

For the second quarter of fiscal 2020, A&P was $47.0, down $0.9 compared to the prior year period. A&P spending as a percent of net sales was 9.0%, compared to 8.8% in the prior year period. The decline was partially due to the impact of the divestiture of the Infant and Pet Care business, which represented A&P expense of $2.2 million in the second quarter of fiscal 2019. Excluding the impact from the Infant and Pet Care business divestiture, A&P spending increased slightly compared to the prior year period, despite a significant pull back to forecast spending in the month of March as a result of COVID-19.

For the first six months of fiscal 2020, A&P was $88.1, down $11.4 as compared to the prior year period. A&P as a percent of net sales was 9.0%, as compared to 9.9% in the prior year period. The decline in A&P was related to the sale of the Infant and Pet Care business, lowering A&P spend by $2.7. Additionally, the decline in A&P was partially related to declines in Wet Shave, primarily in Men’s Systems and Feminine Care across all product types, which were offset in part by increased spend related to Sun and Skin Care including Jack Black, Bulldog, Wet Ones and the Sun Care brands.

### Research and Development Expense

Research and development expense (“R&D”) for the second quarter of fiscal 2020 was $13.9, compared to $14.0 in the prior year period. As a percent of net sales, R&D was 2.7% in the second quarter of fiscal 2020 compared to 2.6% in the prior year period.

R&D for the first six months of fiscal 2020 was $27.7, compared to $26.6 in the prior year period. As a percent of net sales, R&D increased 20 basis points to 2.8% in the first six months of fiscal 2020 from 2.6% in the prior year. The increase in R&D as a percent of net sales compared to the prior year was primarily driven by incremental investments in resources and capabilities in support of the Company’s focus on innovation and development primarily in the Sun and Skin Care segment.

### Interest Expense Associated with Debt

Interest expense associated with debt for the second quarter of fiscal 2020 was $13.9, a decrease from the prior year period of $16.4. For the first six months of fiscal 2020, interest expense was $28.2 compared to $32.4 in the prior year period. The decline in interest expense was the result of lower average outstanding debt primarily related to the $185 term loan due April 2019 that was repaid in the second quarter of fiscal 2019. Additionally, there were no borrowings under the Prior Revolving Credit Facility as of March 31, 2020.

### Other Expense (Income), Net

Other expense (income), net was $10.9 of expense in the second quarter of fiscal 2020 compared to income of $2.7 in the prior year period. Other expense (income), net was an expense of $9.3 during the first six months of fiscal 2020 compared to income of $1.4 during first six months of fiscal 2019. The increase in expense this quarter was largely related to the significant devaluation of local currencies in several key countries in Latin America, Asia and Central Europe against the U.S. dollar and the resulting revaluation of balance sheet exposures, only partially offset by foreign currency exchange contract gains.

### Income Tax Provision

The effective tax rate for the first six months of fiscal 2020 was 27.4% compared to 33.0% in the prior year period. The effective tax rate includes the unfavorable impact of the disposition of the Infant and Pet Care business in the current year. The effective tax rate for the prior period is higher primarily due to $4.7 of tax expense related to net charges from the Tax Act as well as the unfavorable impact of $33.9 of restructuring and other related costs in lower tax rate jurisdictions and unfavorable tax adjustments, including the share-based payment guidance. Excluding the tax impact of restructuring charges, acquisition and integration planning costs, the gain on the disposition of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, and legal settlement expenses, the adjusted effective tax rate was 24.2% and 24.9% for the first six months of fiscal 2020 and fiscal 2019, respectively. Both the effective tax rate and the adjusted effective tax rate are dependent upon the mix of earnings in various tax jurisdictions.

The following table presents a reconciliation of the adjusted effective tax rate, which is a non-GAAP measure:

|  | Six Months Ended March 31, 2020 Reported | Adjustments (1) | Adjusted (Non-GAAP) | Six Months Ended March 31, 2019 Reported | Adjustments (1) | Adjusted (Non-GAAP) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Earnings before income taxes | 57.8 | $48.3 | $106.1 | 71.3 | $37.3 | $108.6 |
| Income tax provision | 15.9 | 9.9 | 25.8 | 23.5 | 3.4 | 26.9 |
| Net earnings | $41.9 | $38.4 | $80.3 | $47.8 | $33.9 | $81.7 |
| Effective tax rate | 27.4% |  |  | 33.0% |  |  |
| Adjusted effective tax rate |  |  | 24.2% |  |  | 24.9% |

(1) Includes adjustments for the impact of the Tax Act, restructuring charges, acquisition and integration planning costs, the gain on the divestiture of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, and legal settlement expense. See reconciliation of net earnings to adjusted net earnings.

### Segment Results

The following tables present changes in segment net sales and segment profit for the second quarter and first six months of fiscal 2020, compared to the corresponding period in fiscal 2019, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings before income taxes, refer to Note 14 of Notes to Condensed Consolidated Financial Statements.

Our operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, a combined sales force and management teams. We apply a fully allocated cost basis, in which shared business functions are allocated between the segments. As a result of the divestiture of the Infant and Pet Care business, some shared costs which were previously allocated to the All Other segment are now being allocated to the Wet Shave, Sun and Skin Care and Feminine Care segments, with the largest impact to Wet Shave, as noted in the discussion below.

### Wet Shave

| Net Sales - Wet Shave Period Ended March 31, 2020 | Q2 | % Chg | Six Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Net sales - prior year | $294.4 |  | $582.1 |  |
| Organic | (10.2) | (3.5)% | (19.6) | (3.4)% |
| Impact of currency | (3.7) | (1.2)% | (5.0) | (0.8)% |
| Net sales - current year | $280.5 | (4.7)% | $557.5 | (4.2)% |

Wet Shave net sales for the second quarter of fiscal 2020 decreased 4.7%, inclusive of a 1.2% decline due to currency movements. Excluding the impact of currency movements, organic net sales decreased $10.2, or 3.5%, primarily driven by volume declines in Men's Systems and unfavorable price mix in disposables with flat volumes. By region, North America organic net sales decreased 3.4% while International markets decreased 3.6%, in large part due to COVID-19 related impacts across many parts of Asia.

Wet Shave net sales for the first six months of fiscal 2020 decreased 4.2%, inclusive of a 0.8% decline due to currency movements. Excluding the impact of currency movements, organic net sales decreased $19.6, or 3.4%. The decline in organic net sales was driven by Men’s Systems and Disposables partially offset by slight gains in Women’s Systems and Shave Preps. North America organic net sales was down 3.2%, while International organic net sales decreased 3.6%. Men's Systems volumes declined in North America due to lower consumption and competition. Additionally, North America experienced unfavorable price mix caused by increased promotional spend primarily in Disposables. Asia Pacific declined nearly 7.0% with lower volumes partially attributable to COVID-19.

| Segment Profit - Wet Shave Period Ended March 31, 2020 | Q2 | % Chg | Six Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Segment profit - prior year | $55.7 |  | $110.7 |  |
| Organic | (10.2) | (18.3)% | (12.2) | (11.0)% |
| Impact of currency | (1.0) | (1.8)% | (1.1) | (1.0)% |
| Segment profit - current year | $44.5 | (20.1)% | $97.4 | (12.0)% |

Wet Shave segment profit for the second quarter of fiscal 2020 was $44.5, down $11.2, or 20.1%, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit decreased $10.2, or 18.3%, driven by lower volumes and unfavorable pricing, as well as higher SG&A due to the reallocation of overhead spending resulting from the Infant and Pet Care business divestiture.

Wet Shave segment profit for the first six months of fiscal 2020 was $97.4, down $13.3 or 12.0%, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit decreased $12.2, or 11.0%, primarily due to lower sales volumes across all categories in North America, and Men’s Systems in Asia Pacific, partially attributable to COVID-19. Unfavorable price mix was the result of increased trade spend in North America. The gross margin declines were partially offset by lower A&P support of the Wet Shave segment across all brands.

### Sun and Skin Care

Sun and Skin Care segment net sales and segment profit are affected by the seasonality of sun care products. As a result, segment net sales and segment profit historically have been higher in the second and third quarters of the fiscal year. Net Sales and Operating Profit for manicure kits were reclassified to Sun and Skin Care for both the current and prior year periods as these products were not a part of the divestiture. The impact of recasting the prior period segment information was not material.

| Net Sales - Sun and Skin Care Period Ended March 31, 2020 | Q2 | % Chg | Six Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Net sales - prior year | $146.0 |  | $213.4 |  |
| Organic | 12.7 | 8.7% | 21.1 | 9.9% |
| Impact of currency | (1.2) | (0.8)% | (1.9) | (0.9)% |
| Net sales - current year | $157.5 | 7.9% | $232.6 | 9.0% |

31

Sun and Skin Care net sales for the second quarter of fiscal 2020 increased 7.9%, inclusive of a 0.8% decline due to currency movements. Excluding the impact of currency movements, organic net sales increased $12.7, or 8.7%, primarily driven by significant volume growth in Wet Ones in North America from increased consumer demand, partially related to COVID-19. Men's Grooming organic net sales increased 10%, while Sun Care sales were flat in the quarter.

Sun and Skin Care net sales for the first six months of fiscal 2020 increased 9.0%, inclusive of a 0.9% decline due to currency movements. Excluding the impact of currency movements, organic net sales increased $21.1, or 9.9%, with gains across all product lines as Wet Ones, Bulldog, Jack Black, and Hawaiian Tropic all had increased sales volumes. Growth in Wet Ones and Men’s Grooming products were primarily in North America and Europe, while Hawaiian Tropic growth was primarily in Asia Pacific through expansion in Oceania.

| Segment Profit - Sun and Skin Care Period Ended March 31, 2020 | Q2 | % Chg | Six Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Segment profit - prior year | $40.7 |  | $40.3 |  |
| Organic | 4.3 | 10.6% | 4.9 | 12.2% |
| Impact of currency | (0.7) | (1.8)% | (0.8) | (2.0)% |
| Segment profit - current year | $44.3 | 8.8% | $44.4 | 10.2% |

Segment profit for the second quarter of fiscal 2020 was $44.3, an increase of $3.6, or 8.8%, compared to the prior year quarter, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit increased $4.3, or 10.6%, driven by higher gross profit from increased volumes related to Wet Ones in North America and Hawaiian Tropic in Asia. These increases were offset by increased A&P spend in support of Jack Black and Bulldog grooming products.

Segment profit for the first six months of fiscal 2020 was $44.4, an increase of $4.1, or 10.2%, inclusive of currency movements. Excluding the impact of currency movements, organic segment profit increased $4.9, or 12.2%, driven primarily by increased sales volumes of Wet Ones products. Outside of Wet Ones, the remaining brands maintained flat operating profits as growth in Hawaiian Tropic was offset by Banana Boat and the Grooming brands continued to reinvest earnings in promotional spending.

### Feminine Care

| Net Sales - Feminine Care Period Ended March 31, 2020 | Q2 | % Chg | Six Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Net sales - prior year | $74.6 |  | $149.3 |  |
| Organic | 10.5 | 14.0% | 11.0 | 7.3% |
| Impact of currency | (0.1) | (0.1)% | (0.2) | (0.1)% |
| Net sales - current year | $85.0 | 13.9% | $160.1 | 7.2% |

Feminine Care net sales for the second quarter of fiscal 2020 increased $10.4, or 13.9%, inclusive of a 0.1% decline due to the impact of currency movements. Feminine Care net sales for the first six months of fiscal 2020 increased $10.8, or 7.2%, inclusive of a 0.1% decline due to the impact of currency movements. Excluding the impact of currency movements, organic net sales increased 14.0% and 7.3% for the three and six months ended March 31, 2020, largely driven by volume growth in o.b., Sport Tampons, Carefree Liners and Stayfree Pads, related to a consumer stock up due to COVID-19.

| Segment Profit - Feminine Care Period Ended March 31, 2020 | Q2 | %Chg | Six Months | %Chg |
| --- | ---: | ---: | ---: | ---: |
| Segment profit - prior year | $13.7 |  | $21.2 |  |
| Organic | 4.5 | 32.8% | 10.1 | 47.6% |
| Impact of currency | 0.1 | 0.7% | 0.1 | 0.5% |
| Segment profit - current year | $18.3 | 33.5% | $31.4 | 48.1% |

Feminine Care segment profit for the second quarter of fiscal 2020 was $18.3, an increase of $4.6, or 33.5%. The increase was driven by increased volumes and favorable price mix, partly offset by higher SG&A due to the reallocation of overhead spending resulting from the Infant and Pet Care business divestiture.

Feminine Care segment profit for the first six months of fiscal 2020 was $31.4, an increase of $10.2, or 48.1%, primarily due to higher sales volumes and favorable cost mix due to lower materials and warehouse and distribution costs. Additionally, the increase was driven by lower A&P in tampons and pads. These gains were partially offset by higher overhead spending.

### All Other

The Infant and Pet Care business divestiture completed in December 2019 disposed of the entirety of operations of the All Other segment. Net Sales and Operating Profit for the Company’s manicure kits were reclassified to Sun and Skin Care for both the current and prior year periods. The results below represent segment performance through the date of divestiture.

| Net Sales - All Other Period Ended March 31, 2020 | Q2 | %Chg | Six Months | %Chg |
| --- | ---: | ---: | ---: | ---: |
| Net sales - prior year | $31.7 |  | $59.0 |  |
| Organic | — | —% | 0.5 | 0.8% |
| Impact of divestiture | (31.7) | (100.0)% | (32.7) | (55.4)% |
| Impact of currency | — | —% | — | —% |
| Net sales - current year | $— | (100.0)% | $26.8 | (54.6)% |

All Other net sales for the first six months of fiscal 2020 decreased 54.6%. Excluding the impact of the divestiture, organic net sales increased $0.5 or 0.8%.

| Segment Profit - All Other Period Ended March 31, 2020 | Q2 | %Chg | Six Months | %Chg |
| --- | ---: | ---: | ---: | ---: |
| Segment profit - prior year | $5.8 |  | $6.8 |  |
| Organic | — | —% | 0.5 | 7.4% |
| Impact of divestiture | (5.8) | (100.0)% | (4.2) | (61.8)% |
| Impact of currency | — | —% | — | —% |
| Segment profit - current year | $— | (100.0)% | $3.1 | (54.4)% |

All Other segment profit for the first six months of fiscal 2020 was $3.1, a decrease of $3.7 or 54.4%, compared to the prior year period. Excluding the impact of the divestiture, organic segment profit increased 7.4%.

### General Corporate and Other Expenses

|  | Quarter Ended March 31, 2020 | 2019 | Six Months Ended March 31, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Corporate expenses | $10.9 | $16.7 | $24.2 | $30.4 |
| Restructuring and related costs | 12.4 | 15.4 | 20.4 | 33.9 |
| Acquisition and integration planning costs | 25.5 | 0.5 | 31.7 | 1.0 |
| Gain on sale of Infant and Pet Care business | 1.1 | — | (4.1) | — |
| Feminine and Infant Care evaluation costs | — | 1.0 | 0.3 | 1.0 |
| Legal settlement expense | — | — | — | 0.9 |
| Sun Care reformulation | — | 0.4 | — | 0.5 |
| General corporate and other expenses | $49.9 | $34.0 | $72.5 | $67.7 |
| % of net sales | 9.5% | 6.2% | 7.4% | 6.7% |

For the second quarter of fiscal 2020, general corporate expenses were $10.9, or 2.1% of net sales, compared to $16.7, or 3.1% of net sales, in the prior year quarter. For the first six months of fiscal 2020, general corporate expenses were $24.2, or 2.5% of net sales, compared to $30.4, or 3.0% of net sales, in the prior year period. For the second quarter and first six months of fiscal 2020, the decline in corporate expense relates to Project Fuel savings, lower compensation and benefits expenses, and prior year legal costs that were not recurring.

For the second quarter and first six months of fiscal 2020, the Company incurred expenses associated with the cancelled acquisition of Harry’s. The acquisition costs were primarily legal and financing costs incurred in the second quarter. The Company does not expect to incur significant expenses associated with the cancelled Harry’s acquisition through the remainder of fiscal 2020.

### Liquidity and Capital Resources

To date, COVID-19 has not had an impact on our liquidity, cash flows or capital resources. However, the continued spread of COVID-19 has led to disruption and volatility in the global capital markets, which, depending on future developments, could impact our capital resources and liquidity in the future.

At March 31, 2020, most of our cash balances were located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material.

The counterparties to deposits consist of a number of major financial institutions. We consistently monitor positions with, and credit ratings of, counterparties both internally and by using outside ratings agencies.

Our total borrowings were $1,117.7 at March 31, 2020 including $17.7 tied to variable interest rates. Our total borrowings at September 30, 2019 were $1,231.4.

As of March 31, 2020, we did not have any outstanding borrowings under our former unsecured revolving credit facility in the U.S. (the “Prior Revolving Facility”). We had $7.4 of outstanding letters of credit. Taking into account outstanding borrowings on the Prior Revolving Facility and outstanding letters of credit, $717.6 remained available under the Prior Revolving Facility at March 31, 2020. On April 3, 2020, we replaced the Prior Revolving Facility with a new revolving credit facility in an aggregate principal amount of $425 (the “Revolving Credit Facility”). As of April 3, 2020, $410.2 was available under the Revolving Credit Facility. At September 30, 2019, we had outstanding borrowings of $117.0 under the Prior Revolving Facility. The Company’s $600 and $500 senior notes are due May 19, 2021 and May 24, 2022, respectively. We are evaluating our options related to these senior notes including refinancing the senior notes prior to their maturity or repayment using cash on hand and available borrowing under the Revolving Facility.

We had outstanding international borrowings, recorded in Notes payable, of $17.7 and $14.4 as of March 31, 2020 and September 30, 2019, respectively.

Historically, we have generated and expect to continue to generate positive cash flows from operations. Our cash flows are affected by the seasonality of our Sun Care products, resulting in higher net sales and increased cash generated in the second and third quarter of each fiscal year. However, due to the impact of COVID-19 we expect our sales for Sun Care to be weaker due to the current stay at home orders and travel restrictions. While we cannot reasonably estimate the full impact COVID-19 will have on our cash flows, we believe our cash on hand, cash flows from operations and available borrowing under the Revolving Credit Facility will be sufficient to satisfy our future working capital requirements, interest payments, research and development activities, capital expenditures, and other financing requirements for at least the next 12 months. We will continue to monitor our cash flows, spending and liquidity needs.

Short-term financing needs primarily consist of working capital requirements, and principal and interest payments on our long-term debt. Long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and repayment or refinancing of our long-term debt obligations. We may, from time-to-time, seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt, and raise equity under terms that are favorable to us.

The expected minimum required contribution to our pension plans in fiscal 2020 is $10.4; however, discretionary contributions may also be made. During the first six months of fiscal 2020 we contributed $2.7 to our pension plans.

As of March 31, 2020, we were in compliance with the provisions and covenants associated with our debt agreements.

### Cash Flows

A summary of our cash flow activities is provided in the following table:

| Net cash from (used by): | Six Months Ended March 31, 2020 | 2019 |
| --- | ---: | ---: |
| Operating activities | $17.2 | $(31.9) |
| Investing activities | 81.1 | (13.9) |
| Financing activities | (130.5) | 27.3 |
| Effect of exchange rate changes on cash | (0.6) | (3.3) |
| Net decrease in cash and cash equivalents | $(32.8) | $(21.8) |

#### Operating Activities

Cash flow from operating activities was $17.2 during the first six months of fiscal 2020, compared to cash outflows of $31.9 during the same period in the prior year. The improvement in cash generated from operating cash flows was primarily related to improved working capital due to lower inventory impacted by Feminine Care demand and efforts to optimize inventory levels across all portfolios. Additionally, accounts receivable improved from the timing of collections.

#### Investing Activities

Cash flow from investing activities was $81.1 during the first six months of fiscal 2020, compared to cash used by investing activities of $13.9 during the same period in the prior year. During the six months ended March 31, 2020, we collected $95.8 of proceeds from the sale of the Infant and Pet Care business. Capital expenditures were $16.8 during the first six months of fiscal 2020 compared to $22.9 during the same period in the prior year. Additionally, other investing cash inflows totaled $2.1 during the first six months of fiscal 2020 compared to $9.0 in the prior year period.

#### Financing Activities

Net cash used by financing activities was $130.5 during the first six months of fiscal 2020, compared to net cash from financing activities of $27.3 during the same period in the prior year. During the six months of fiscal 2020, we made repayments of $117.0 on the Prior Revolving Facility. Additionally, financing outflows associated with the Accounts Receivable Facility were $14.4 during the first six months of fiscal 2020 compared to financing inflows of $2.3 in the prior year period.

### Commitments and Contingencies

#### Contractual Obligations

During the first six months of fiscal 2020, net repayments on our revolving credit facilities were $117.0. As of March 31, 2020, future minimum repayments of debt were: $600.0 in fiscal 2021, and $500.0 in fiscal 2022.

There have been no other material changes in our contractual obligations since the presentation in our 2019 Annual Report.

### Supplemental Guarantor Financial Information

The Company issued senior notes in May 2011 and May 2012 (collectively, the “Notes”) and entered into the Revolving Credit Facility on April 3, 2020, all of which are fully and unconditionally guaranteed on a joint and several basis by the Company’s existing and future material direct and indirect domestic subsidiaries that are guarantors of any of the Company’s credit agreements or other indebtedness for borrowed money (the “Guarantors”). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company’s obligations under the Notes and the Revolving Credit Agreement. The Company’s subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company’s other indebtedness (collectively, the “Non-Guarantors”), do not guarantee the Notes. The subsidiary guarantee with respect to the Notes is subject to release upon sale of all of the capital stock of the subsidiary guarantor; if the guarantee under the Company’s credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture. Further detail on the Revolving Credit Facility is included in Note 10 of Notes to Consolidated Financial Statements

The following tables present summarized financial information for the Parent and the Guarantors on a combined basis after elimination of (i) intercompany transactions and balances among the Parent and the Guarantors and (ii) equity in earnings from and investments in any subsidiary that is a non-Guarantor.

| Summarized Statement of Operations | Six Months Ended March 31, 2020 |
| --- | ---: |
| Net sales | $652.9 |
| Gross profit | 255.1 |
| Net earnings | 8.9 |

| Summarized Balance Sheet Assets | March 31, 2020 | September 30, 2019 |
| --- | ---: | ---: |
| Current assets | $405.1 | $299.1 |
| Non-current assets | 1,667.1 | 1,745.5 |
| **Liabilities and Shareholder’s Equity** |  |  |
| Current liabilities | 340.1 | 487.5 |
| Non-current liabilities | 1,388.6 | 1,393.2 |

37

## Market risk

As filed, 1,196 characters.

The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in currency rates, commodity prices, and interest rates. At times, we enter into contractual arrangements (derivatives) to reduce these exposures. For further information on our foreign currency derivative instruments, refer to Note 13 of Notes to Condensed Consolidated Financial Statements. As of March 31, 2020, there were no open derivative or hedging instruments for future purchases of raw materials or commodities. Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on LIBOR plus margin. As of March 31, 2020, our outstanding variable-rate debt included $17.7 related to our international, variable-rate note payable. Assuming a one-percent increase in the applicable interest rates, annual interest expense on these variable-rate debt instruments would not increase materially.

There have been no material changes in our assessment of market risk sensitivity since our presentation of Quantitative and Qualitative Disclosures About Market Risk in our 2019 Annual Report on Form 10-K.

## Controls and procedures

As filed, 1,198 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized, and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure.

Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2020. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.

### Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2020 that have materially affected, or are likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 2,309 characters.

While we attempt to identify, manage and mitigate risks and uncertainties associated with our business to the extent practical under the circumstances, some level of risk and uncertainty will always be present. Item 1A. Risk Factors of our 2019 Annual Report on Form 10-K describes some of the risks and uncertainties associated with our business. These risks and uncertainties have the potential to materially affect our business, results of operations, financial condition, cash flows, projected results and future prospects. Except for the risk factor discussed below, we do not believe that there have been any material changes to the risk factors disclosed in our 2019 Annual Report on Form 10-K.

**The effects of COVID-19 and other potential future public health crises, epidemics, pandemics or similar events on our business, operating results and cash flows are uncertain and could be material.**

Our business and financial results may be negatively impacted by health epidemics, pandemics and similar outbreaks. COVID-19, and the global requirements to take action to help limit the spread of the illness, will impact our ability to carry out our business as usual and may materially adversely impact global economic conditions, our business, results of operations, cash flows and financial condition. Even in those regions where we are currently experiencing initial business recovery, should those regions fail to fully contain COVID-19 or suffer a recurrence of an outbreak of COVID-19, our businesses located in those regions may not recover as quickly or at all, which could have a material adverse effect on our business and results of operations, including:

- causing significant volatility in demand for our products;
- changes in consumer behavior and preference;
- disruptions in our manufacturing and supply chain operations;
- disruptions to our cost saving programs and restructuring initiatives;
- limitations on our employees’ ability to work and travel;
- significant changes in the economic or political conditions in markets in which we operate; and
- related currency and commodity volatility.

We cannot predict the degree to, or the time period over, which our sales and operations may be affected by this outbreak and preventative measures, and the effects could be material.

Filed May 7, 2020.
Source: SEC EDGAR, the filing index for accession 0001096752-20-000024. Last ingested by Listed: Nov 14, 2026, 23:53 ET. No prices; not investment advice.
